Innovating Works

EPDA

Desconocido
BICEPS: Beyond neuroInflammation new Concepts to Elucidate the immune system s vital role in Parkinson s di... Decades of research into Parkinson's disease (PD) have fallen short in fully comprehending its mechanisms, leaving us without a cure. Curren...
2024-06-25 - 2028-10-31 | Financiado
TreatER: Clinical study in Parkinson s disease with two unique goals 1 Proof of concept of CDNF protein for... ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON participó en un H2020: H2020-SC1-2016-2017 The main focus of TreatER is conducting a randomized, placebo-controlled, first-in-human, proof-of-concept, safety and efficacy study of int...
2016-12-09 - 2020-12-31 | Financiado
NRT: Phase II clinical trial of PDGF BB for the neurological regeneration and recovery in Parkinson s dis... The goal of this project is to perform a European phase II clinical trial to demonstrate that PDGF-BB acts as a unique regenerative therapy...
Financiado
REPLACES: Restorative Plasticity At Corticostriatal Excitatory Synapses ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON participó en un FP7: Long-lasting, activity-dependent synaptic changes are thought to underlie the ability of the brain to translate experiences into memories an...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.